Glen Harbor Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $80K | Hold |
1,408
| – | – | ﹤0.01% | 1200 |
|
|
2019
Q2 | $78K | Hold |
1,408
| – | – | ﹤0.01% | 1207 |
|
|
2019
Q1 | $71K | Hold |
1,408
| – | – | ﹤0.01% | 1194 |
|
|
2018
Q4 | $57K | Buy |
1,408
+272
| +24% | +$11K | ﹤0.01% | 1180 |
|
|
2018
Q3 | $79K | Buy |
1,136
+96
| +9% | +$6.68K | ﹤0.01% | 1210 |
|
|
2018
Q2 | $79K | Hold |
1,040
| – | – | ﹤0.01% | 1169 |
|
|
2018
Q1 | $55K | Buy |
1,040
+176
| +20% | +$9.31K | ﹤0.01% | 1225 |
|
|
2017
Q4 | $46K | Buy |
864
+160
| +23% | +$8.52K | ﹤0.01% | 1235 |
|
|
2017
Q3 | $42K | Buy |
704
+208
| +42% | +$12.4K | ﹤0.01% | 1223 |
|
|
2017
Q2 | $39K | Buy |
496
+272
| +121% | +$21.4K | ﹤0.01% | 1230 |
|
|
2017
Q1 | $19K | Buy |
+224
| New | +$19K | ﹤0.01% | 1244 |
|